INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RD
Ruppel Christian Devininterim President
GDOTGREEN DOT CORP
Tax withholding
F$2,195
169 sh
Dec 15, 2025Dec 16, 2025
Page 1650 of 1855
← PrevNext →
traded Dec 15, 2025
+1d
SEC Form 4

Evidence

9
SD
Strong DanaDirector
ELESTEE LAUDER COMPANIES INC
Grant or award
A$274
3 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
CT
Clarke TraffordDirector
TRAWTraws Pharma, Inc.
Grant or award
A—
6,157 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
LJ
Ledet Aaron JEVP, I&D & Supply Chain
LYBLyondellBasell Industries N.V.
Tax withholding
F$2,167
50 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
YN
Yokozuka NorikoGeneral Counsel
PRMPerimeter Solutions, Inc.
Option exercise
M—
17.5K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
MP
Marino Jason P.See Remarks
VACMARRIOTT VACATIONS WORLDWIDE Corp
Tax withholding
F$5,161
89 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
GD
Graeler DarrenChief Accounting Officer
LDIloanDepot, Inc.
Option exercise
M—
18.6K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
SS
Sanfrey Jeffrey ScottChief Operating Officer
BLBDBlue Bird Corp
Tax withholding
F$28K
549 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
WS
Weber Robert ScottGeneral Counsel
ATENA10 Networks, Inc.
Tax withholding
F$17K
925 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
ST
Scartz TedSVP General Counsel
BLBDBlue Bird Corp
Tax withholding
F$32K
626 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
SK
Soares KarenGeneral Counsel & Secretary
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$17K
6,404 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
ES
Egan ScottDirector, Chief Executive Officer
SPNTSiriusPoint Ltd
Tax withholding
F—
21.8K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
NA
Nunez ArturoDirector
ELESTEE LAUDER COMPANIES INC
Grant or award
A$1,481
15 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
PB
Patel BhadreskumarCOO
RGPRESOURCES CONNECTION, INC.
Grant or award
A—
912 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
WA
Weigensberg AryeSee Remarks
CRONCronos Group Inc.
Option exercise
M—
6,423 sh
Dec 13, 2025Dec 16, 2025
traded Dec 13, 2025
+3dSEC Form 4

Evidence

9
GD
Graeler DarrenChief Accounting Officer
LDIloanDepot, Inc.
Tax withholding
F$22K
9,074 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
NE
Nierenberg EricEVP, CFO AND TREASURER
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
2 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
LA
Lalvani AmarSee Remarks
HHyatt Hotels Corp
Option exercise
M—
1,548 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$149K
8,000 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
BS
Butera Stephanie SobeckSee Remarks
VACMARRIOTT VACATIONS WORLDWIDE Corp
Tax withholding
F$5,161
89 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
PA
Pighini Kathleen A.See Remarks
VACMARRIOTT VACATIONS WORLDWIDE Corp
Tax withholding
F$1,508
26 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
LB
Langan BrianSee Remarks
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
2 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
HJ
Harinstein JasonDirector
FNKOFunko, Inc.
Option exercise
M—
3,108 sh
Dec 13, 2025Dec 16, 2025
traded Dec 13, 2025
+3dSEC Form 4

Evidence

9
WR
Warner RoxanneEVP Finance & Corp. Controller
WHRWHIRLPOOL CORP /DE/
Tax withholding
F$33K
429 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
KA
Koehler AllisonChief Legal Officer
BARKBark, Inc.
Tax withholding
F$1,836
2,915 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

9
PD
Pauza Charles DavidChief Science Officer Virology
TRAWTraws Pharma, Inc.
Grant or award
A—
73.9K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
65.7K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

9
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$8,752
1,013 sh
Dec 13, 2025Dec 16, 2025
traded Dec 13, 2025
+3dSEC Form 4

Evidence

9
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$84K
4,500 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

8
TD
Tesh Thomas DChief Admin. Officer
ROLROLLINS INC
Open-market sale · 10b5-1 plan
SELL$143K
2,396 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

8
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Gift
G—
115 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

8
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Gift
G—
180 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

8
GH
Gan HongCHIEF SCIENCE OFFICER
SESSES AI Corp
Open-market sale · 10b5-1 plan
SELL$198K
100.0K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

8
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Gift
G—
6,667 sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

8
BS
Blanchard SarahChief Financial Officer
UDMYUdemy, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
25.0K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence

7
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Dec 16, 2025Dec 16, 2025
traded Dec 16, 2025
+0dSEC Form 4

Evidence

7
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Derivative conversion · 10b5-1 plan
C—
506.0K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC Form 4

Evidence

7
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Dec 16, 2025Dec 16, 2025
traded Dec 16, 2025
+0dSEC Form 4

Evidence

7
CF
Coddington Elizabeth FChief Financial Officer
PTONPELOTON INTERACTIVE, INC.
Option exercise · 10b5-1 plan
M—
21.8K sh
Dec 13, 2025Dec 16, 2025
traded Dec 13, 2025
+3dSEC Form 4

Evidence

7
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Derivative conversion · 10b5-1 plan
C—
232.5K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC Form 4

Evidence